Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation.
Lee
S-H
SH
Kim
B-C
BC
Yang
D-H
DH
Park
M-S
MS
Choi
S-M
SM
Kim
M-K
MK
Cho
K-H
KH
D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods; D001925:Brain Damage, Chronic / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D019703:Calcineurin / Q000378:metabolism; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000009:adverse effects; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006624:Hippocampus / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008569:Memory Disorders / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D009483:Neuropsychological Tests; D020258:Neurotoxicity Syndromes / Q000175:diagnosis; D016559:Tacrolimus / Q000009:adverse effects
D065095:Calcineurin Inhibitors; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus